Register to chat with like-minded investors on our interactive forums.
Period:
Draw Mode:
| Volume | 51,649 |
|
|||||
| News | - | ||||||
| Day High | 0.3992 | Low High |
|||||
| Day Low | 0.3556 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Galmed Pharmaceuticals Ltd | GLMD | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.0386 | 10.68% | 0.40 | 20:00:00 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 0.3794 | 0.3556 | 0.3992 | 0.40 | 0.3614 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 181 | 51,649 | $ 0.3668843 | $ 18,949 | - | 0.26 - 7.80 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 19:35:58 | 24 | $ 0.3899 | USD |
Galmed Pharmaceuticals Ltd Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 672k | 1.68M | - | 0 | -6.91M | -4.11 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Galmed Pharmaceuticals News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical GLMD Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.3487 | 0.3992 | 0.3354 | 0.3667109 | 44,632 | 0.0513 | 14.71% |
| 1 Month | 0.32 | 0.44 | 0.315 | 0.3730756 | 269,710 | 0.08 | 25.00% |
| 3 Months | 0.3895 | 0.4688 | 0.30 | 0.3534807 | 226,001 | 0.0105 | 2.70% |
| 6 Months | 0.37 | 0.47 | 0.26 | 0.3704714 | 195,363 | 0.03 | 8.11% |
| 1 Year | 4.7835 | 7.80 | 0.26 | 1.97 | 230,304 | -4.38 | -91.64% |
| 3 Years | 48.45 | 61.20 | 0.26 | 17.26 | 171,308 | -48.05 | -99.17% |
| 5 Years | 124.05 | 127.581 | 0.26 | 35.04 | 155,130 | -123.65 | -99.68% |
Galmed Pharmaceuticals Description
| Galmed Pharmaceuticals Ltd is a biopharmaceutical company. It focuses on the development and commercialization of once-daily, oral therapy for the treatment of liver diseases and cholesterol gallstones utilizing its synthetic fatty-acid/bile-acid conjugate (FABAC), called aramchol. Its product, aramchol, is a disease-modifying treatment for fatty liver disorders, including Non-Alcoholic Steato-hepatitis. Aramchol affects liver fat metabolism and has been shown in a Phase IIa clinical study to reduce liver fat content, as well as improve metabolic parameters associated with Nonalcoholic steatohepatitis. |
